Operating under scant regulation and disparate safety standards, more than 500 businesses offer the powerful mind-altering drug nationwide, according to a 2024 report released by the Drug Enforcement Administration, often for patients to take at home without medical supervision
Revlimid (lenalidomide) Disease area(s): Oncology/hematology Manufacturer(s): Bristol Myers Squibb 2024 Sales (USD): $5.77 billion Why it sold so well: In 2024, BMS Revlimid generated $5.77 billion in global revenue, maintaining its position as one of the companys top-selling products despite facing generic competition
A 2025 report from Peninsula Plastic Surgery, 80% of users reported improved hair growth , reinforces that hair outcomes are the products primary, measurable result, and that behavioral cascades are the plausible path to any downstream weight effects
Through this partnership, eligible UnitedHealthcare PPO members can receive personalized medical care, lifestyle coaching, and expert weight loss supportall covered by their insurance plan
Its a good starting point, but it doesnt account for all the factors that may affect your daily energy needs